Seritage Growth Properties

Seritage Growth Properties (the “Company”) is unable to file, without unreasonable effort and expense, its Quarterly Report on Form 10-Q for the three months ended June 30, 2024 (the “Q2 Form 10-Q”) by the prescribed due date. The Company experienced an unexpected delay in finalizing the financial statements in the Q2 Form 10-Q relating to the assessment of one impairment with respect to one real estate asset. Specifically, the Company expects to recognize a material non-cash impairment charge with respect to such real estate asset. The Company is continuing to evaluate its portfolio, including its development plans and holding periods, which may result in additional impairments in future periods. The Company is working to complete the impairment analysis. The Company intends to file the Q2 Form 10-Q as soon as practicable. Forward-Looking Statements This Form 12b-25 includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including with respect to the timing of the filing of the Q2 Form 10-Q. Such forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: the risk that the impairment discussed herein is more than currently expected by the Company, the risk that the Q2 Form 10-Q is not filed within the extension period identified herein, the risk of deficiencies or weaknesses in internal controls and other risks identified in the Company’s most recent filing on Form 10-K and other SEC filings, all of which are available on the Company’s website. The Company does not undertake to update its forward-looking statements unless otherwise required by the federal securities laws

Seritage Growth Properties (the “Company”) needs additional time to evaluate and conclude on their assessment of the internal control over financial reporting, and as a result Deloitte & Touche LLP, the Company’s independent registered public accounting firm is unable to complete its audit procedures, including its evaluation of the Company's internal control over financial reporting, and render its audit opinion on the consolidated financial statements as of and for the year ended December 31, 2023 by March 15, 2024. The Company fully expects to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “Form 10-K”) within the extension period of 15 calendar days as provided under Rule 12b-25 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-Looking Statements This Form 12b-25 includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including with respect to the timing of the filing of the Form 10-K. Such forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: the risk that the Form 10-K is not filed within the extension period prescribed by Rule 12b-25 and other risks identified in the Company’s most recent filing on Form 10-K and other SEC filings, all of which are available on the Company’s website. The Company does not undertake to update its forward-looking statements unless otherwise required by the federal securities laws

Seritage Growth Properties (the “Company”) is unable to file, without unreasonable effort and expense, its Quarterly Report on Form 10-Q for the three months ended June 30, 2023 (the “Q2 Form 10-Q”) by the prescribed due date. The Company experienced an unexpected delay in finalizing the financial statements in the Q2 Form 10-Q relating to the assessment of one impairment with respect to one real estate asset. Specifically, the Company expects to recognize a material non-cash impairment charge with respect to such real estate asset. The Company is continuing to evaluate its portfolio, including its development plans and holding periods, which may result in additional impairments in future periods. The Company is working to complete the impairment analysis. The Company intends to file the Q2 Form 10-Q as soon as practicable. Forward-Looking Statements This Form 12b-25 includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including with respect to the timing of the filing of the Q2 Form 10-Q. Such forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: the risk that the impairment discussed herein is more than currently expected by the Company, the risk that the Q2 Form 10-Q is not filed within the extension period identified herein, the risk of deficiencies or weaknesses in internal controls and other risks identified in the Company’s most recent filing on Form 10-K and other SEC filings, all of which are available on the Company’s website. The Company does not undertake to update its forward-looking statements unless otherwise required by the federal securities laws